Patrick Gosselin
About Patrick Gosselin
Patrick Gosselin Vice-President — Pharmaceutical R&D
Patrick Gosselin serves as the Vice-President of Pharmaceutical Research and Development. In this role, he oversees the development and innovation of new pharmaceutical products, ensuring these products meet regulatory standards and are brought to market effectively. He works closely with various departments within the organization, providing strategic direction and support to drive research initiatives forward.
Patrick Gosselin Education and Expertise
Patrick Gosselin holds a bachelor's degree in chemical engineering and a doctorate in pharmaceutical technology from the Université de Montréal. His educational background provides a strong foundation in both the technical and practical aspects of pharmaceutical development. His expertise spans across various facets of chemical engineering and pharmaceutical technology, making him a valuable asset in the field of pharmaceutical research and development.
Patrick Gosselin Professional Background
Patrick Gosselin has worked for several major companies in a variety of roles throughout his career. Notably, he has served as an R&D project leader for ratiopharm international. In this capacity, he managed research projects, guiding them from the initial concept phase through to development and implementation. His diverse experience in different organizational roles has equipped him with a broad understanding of the pharmaceutical industry.
Patrick Gosselin Academic Involvement
Patrick Gosselin is an associate professor at the Université du Québec à Montréal. His role in academia involves teaching, mentoring, and guiding students in their research endeavors. He shares his extensive knowledge and industry experience with the next generation of professionals, contributing to the academic community and fostering innovation in pharmaceutical sciences.
Patrick Gosselin Publications and Patents
Patrick Gosselin has published peer-reviewed publications and holds patents in the field of pharmaceutical technology. His work contributes to the body of knowledge in the industry, driving advancements and innovation. His research and patents reflect his commitment to improving pharmaceutical processes and developing new technologies.